1887
Volume 2024, Issue 2
  • E-ISSN: 2220-2749

The procurement of medicines places a heavy burden on the healthcare budget. The emergence of generic medicines as a low-cost alternative to the more expensive branded drugs has been of considerable help to developing countries such as Mauritius. However, the negative perception of the quality and efficacy of generic medicines has always been a controversial topic.

This study focused on understanding patients’ perceptions towards the generic drugs available in the public healthcare sector.

A questionnaire assessing various aspects such as knowledge about generics, beliefs about safety and efficacy of generic drugs, and lack of communication and education about generic medicines was administered to 395 respondents.

A vast majority of the participants (74%) were unaware that the drugs available in public hospitals are generics. Although the respondents believed (76%) that generics were cheaper than branded drugs, they were unaware of the similarity in the composition of generics and branded drugs (55%). Statistically significant relationships were found between demographic factors such as gender, education, and knowledge of generic drugs. Respondents also noted a difference between medicines purchased from private pharmacies and those purchased from public pharmacies. The need to sensitize patient awareness of generic drugs was also identified.

This study was successful in analyzing the factors influencing the knowledge about generic drugs, analyzing the beliefs about safety and efficacy, the perception towards generic medicines in the public and private sectors. Strategies need to be developed to inform healthcare professionals and patients about generic drugs and their potential benefits. However, strict guidelines should be introduced to control the quality, efficacy, and safety of generic drugs before use to increase patient confidence.

Loading

جارٍ تحميل قياسات المقالة...

/content/journals/10.5339/avi.2024.10
٢٠٢٤-١٢-٣٠
٢٠٢٥-١٢-١٦

القياسات

Loading full text...

Full text loading...

/deliver/fulltext/avi/2024/2/avi.2024.10.html?itemId=/content/journals/10.5339/avi.2024.10&mimeType=html&fmt=ahah

References

  1. Bindman AB. Rising Prices and Health Care ‘Empires’. JAMA 2020 Mar 3; 323:(9):815–816. doi: 10.1001/jama.2020.1370.
    [Google الباحث العلمي]
  2. Graves JA, Baig K, Buntin M. The financial effects and consequences of COVID-19: A gathering storm. JAMA 2021 Nov 16; 326:(19):1909–1910. doi: 10.1001/jama.2021.18863.
    [Google الباحث العلمي]
  3. Charan J, Saxena D, Chaudhari M, Dutta S, Kaur RJ, Bhardwaj P. Opinion of patients seeking primary care regarding prescription of generic drugs: A cross-sectional study. J Family Med Prim Care 2020 Nov 30; 9:(11):5725–5730. doi: 10.4103/jfmpc.jfmpc_1694_20. Dutta et al. (2020).
    [Google الباحث العلمي]
  4. Alfonso-Cristancho R, Andia T, Barbosa T, Watanabe JH. Definition and classification of generic drugs across the world. Appl Health Econ Health Policy 2015 Jun 20; 13:(Suppl 1):5–11. doi: 10.1007/s40258-014-0146-1.
    [Google الباحث العلمي]
  5. Monteiro WM, Melo GC, Massunari GK, Hübner DV, Tasca RS. Avaliação da disponibilidade de medicamentos genéricos em farmácias e drogarias de Maringá(PR) e comparação de seus preços com os de referência e similares. Rev Bras Cienc Farm. 2005 Sep; 41:(3):333–343. doi: 10.1590/S1516-93322005000300006.
    [Google الباحث العلمي]
  6. García AJ, Martos F, Leiva F, Sánchez D. La Cuesta F. (2003) Generic drugs: Good or bad? Physician's knowledge of generic drugs and prescribing habits. Gac Sanit. 2003 Mar–Apr;17(2):144–149. doi: 10.1016/s0213-9111(03)71712-9.
    [Google الباحث العلمي]
  7. Vallès JA, Barreiro M, Cereza G, Ferro JJ, Martinez MJ, Cucurrull E, et al. Acceptance of generic prescribing in general practice: Effect of patient education and reference prices. Gac Sanit. 2002 Nov–Dec;(6):505–510. doi: 10.1016/s0213-9111(02)71972-9.
    [Google الباحث العلمي]
  8. Arcaro R, da Veig CRP, da Silva WV, Pereira da Veiga C. Attitude and purchase intention to generic drugs. Int J Environ Res Public Health 2021 Apr 26; 18:(9):4579. doi: 10.3390/ijerph18094579.
    [Google الباحث العلمي]
  9. Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med 2015 Jul 29;13:173. doi: 10.1186/s12916-015-0415-3.
    [Google الباحث العلمي]
  10. Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns 2008 Nov;73(2):377–383. doi: 10.1016/j.pec.2008.07.012.
    [Google الباحث العلمي]
  11. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients’ perceptions of generic medications. Health Aff (Millwood). 2009 Mar-Apr;28(2):546–556. doi: 10.1377/hlthaff.28.2.546.
    [Google الباحث العلمي]
  12. Alam MM, Sikdar P, Kumar A, Mittal A. Assessing adherence and patient satisfaction with medication: Validation of TSQM in emerging markets. Int J Pharm Healthc Mark. 2018;12(4):409–432. doi: 10.1108/IJPHM-10-2016-0053.
    [Google الباحث العلمي]
  13. Joshi SS, Shetty YC, Karande S. Generic drugs - The Indian scenario. J Postgrad Med 2019 Apr–Jun; 65:(2):67–69. doi: 10.4103/jpgm.JPGM_420_18.
    [Google الباحث العلمي]
  14. Shikiar R, Rentz AM. Satisfaction with medication: An overview of conceptual, methodologic, and regulatory issues. Value Health 2004 Mar-Apr; 7:(2):204–215. doi: 10.1111/j.1524-4733.2004.72252.x.
    [Google الباحث العلمي]
  15. WHO Mauritius, Country Cooperation Strategy at a Glance; 2017. Available from: https://www.who.int/publications/i/item/WHO-CCU-18.02-Mauritius [Accessed on 11 November 2023].
  16. Jeetoo J, Vishal Chand J. An empirical analysis of income elasticity of out-of-pocket healthcare expenditure in Mauritius. Healthcare (Basel). 2022 Jan 5; 10:(1):101. doi: 10.3390/healthcare10010101.
    [Google الباحث العلمي]
  17. Guttier MC, Silveira MPT, Luiza VL, Bertoldi AD. Factors influencing the preference for purchasing generic drugs in a Southern Brazilian city. Rev Saude Publica. 2017 Jun 26;51:59. doi: 10.1590/S1518-8787.2017051006786.
    [Google الباحث العلمي]
  18. Lleras-Muney A, lichtenberg FR. Are the more educated more likely to use new drugs? Annales d'Économie et de Statistique. 2005; 79/80::671–696. doi: 10.2307/20777592.
    [Google الباحث العلمي]
  19. Ito Y, Hara K, Yoo B-K, Tomio J, Kobayashi Y. Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs. BMC Health Serv Res. 2019 Nov 1; 19:(1):780. doi: 10.1186/s12913-019-4598-8.
    [Google الباحث العلمي]
  20. Liang BA, Mackey TK. Prevalence and global health implications of social media in direct-to-consumer drug advertising. J Med Internet Res 2011 Aug 31; 13:(3):e64. doi: 10.2196/jmir.1775.
    [Google الباحث العلمي]
  21. Tyrawski J, DeAndrea DC. Pharmaceutical companies and their drugs on social media: A content analysis of drug information on popular social media sites. J Med Internet Res 2015 Jun 1; 17:(6):e130. doi: 10.2196/jmir.4357.
    [Google الباحث العلمي]
  22. Toklu HZ, Dülger GA, Hıdıroğlu S, Akici A, Yetim A, Gannemoğlu HM, et al. Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul – Turkey. Pharm Pract (Granada). 2012 Dec 31; 10:(4):199–206. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/4.
    [Google الباحث العلمي]
  23. Jangra S, Bhyan B, Nair A. Perception on generic drugs among general populace visiting a community pharmacy Jaipur, Rajasthan. J Drug Deliv Ther 2018 Nov–Dec; 8:(6):192–194. doi: 10.22270/jddt.v8i6.2040.
    [Google الباحث العلمي]
  24. Tripathi S, Bhattacharya S. Patient perception about generic vs. branded medicines prescribed in a Tertiary Care Hospital in Northern India – a descriptive study. Ind J Pharm Pract. 2018 Apr–Jun; 11:(2):91–95. doi: 10.5530/ijopp.11.2.19.
    [Google الباحث العلمي]
  25. Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Patients’ attitudes towards generic drug substitution in Japan. Health Policy 2011 Jan; 99:(1):60–65. doi: 10.1016/j.healthpol.2010.07.006.
    [Google الباحث العلمي]
  26. Sharif SI, Aldayeh S, Alsomali H, Hayat F. Assessment of the knowledge and perception of generic medications among pharmacy and medical students in the University of Sharjah, United Arab Emirates. J Gen Med. Business J Gen Med Sector. 2020 May 28; 16:(3):174113432092664. doi: 10.1177/1741134320926642.
    [Google الباحث العلمي]
  27. Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017 Jan; 97:(1):1–37. doi: 10.1152/physrev.00021.2015.
    [Google الباحث العلمي]
  28. Kjoenniksen I, Lindbaek M. Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006 Oct; 28:(5):284–289. doi: 10.1007/s11096-006-9043-5.
    [Google الباحث العلمي]
  29. Aivalli PK, Elias MA, Pati MK, Bhanuprakash S, Munegowda C, Shroff ZC, et al. Perceptions of the quality of generic medicines: Implications for trust in public services within the local health system in Tumkur, India. BMJ Glob Health 2018 Jan 13; 2:(Suppl 3):e000644. doi: 10.1136/bmjgh-2017-000644.
    [Google الباحث العلمي]
  30. Basu S, Andrews J, Kishore S, Panjabi R, Stuckler D. (2012). Comparative performance of private and public healthcare systems in low- and middle-income countries: A systematic review. PLoS Med. 2012 Jun 19; 9:(6):e1001244. doi: 10.1371/journal.pmed.1001244.
    [Google الباحث العلمي]
  31. Al Amer MN, Nayuni N, Anil Kumar KG, Perrett D, Tucker A, Johnston A. The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing. Results Pharma Sci. 2011 Dec 7;2:1–8. doi: 10.1016/j.rinphs.2011.12.001.
    [Google الباحث العلمي]
  32. Hohmann NS, Garza KB, Surry D, Hansen RA, Harris I, Kiptanui Z, et al. Communicating benefits and risks of generic drugs to consumers: Patient and caregiver opinions of two FDA-developed educational materials. Res Social Adm Pharm. 2019 Dec; 15:(12):1489–1493. doi: 10.1016/j.sapharm.2019.01.013.
    [Google الباحث العلمي]
  33. Hassali MA, Shafie AA, Saleem F, Atif M, Chua GN, Masood I, et al. PHP83 community pharmacist's perceptions towards the quality of locally manufactured generic medicines: A descriptive study from Malaysia. Value Health. 2012 Nov; 15:(7):A623. doi: 10.1016/j.jval.2012.08.127.
    [Google الباحث العلمي]
  34. Drozdowska A, Hermanowski T. Exploring factors underlying the attitude of community pharmacists to generic substitution: A nationwide study from Poland. Int J Clin Pharm 2016 Feb; 38:(1):162–170. doi: 10.1007/s11096-015-0227-8.
    [Google الباحث العلمي]
  35. Hassali MA, Alrasheedy AA, McLachlan A, Nguyen TA, Al-Tamimi SK, Ibrahim MIM. The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J 2014 Dec; 22:(6):491–503. doi: 10.1016/j.jsps.2013.12.017.
    [Google الباحث العلمي]
/content/journals/10.5339/avi.2024.10
Loading
/content/journals/10.5339/avi.2024.10
Loading

جارٍ تحميل البيانات والوسائط...

  • نوع المستند: Research Article
الموضوعات الرئيسية Generic drugsperception about generic drugs and safety and efficacy of medicines

الأكثر اقتباسًا لهذا الشهر Most Cited RSS feed

هذه الخانة مطلوبة
يُرجى إدخال عنوان بريد إلكتروني صالح
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error